Our Global Portfolio for Cardiovascular Health

A Global Leader in Cardiovascular Disease

Amarin is a global pharmaceutical company, focused on addressing cardiovascular health. We apply science, passion, and our global resources to support our BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide and to significantly improve lives.

+$3.2B

Revenue since launch

46 Countries

Countries with regulatory approvals for cardiovascular risk reduction

50+

Global medical societies endorse data

ALL-NP-00015 1/23